(Total Views: 195)
Posted On: 04/04/2017 10:32:13 AM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: someconcerns #32777
"Cancer drugs don't compete on price," said Dr. Aaron Kesselheim, a researcher at Harvard Medical School and author of several studies of drug pricing. "Drug companies have market exclusivity and we require payers to cover cancer drugs - Medicare has six protected classes, including cancer."
Read More: http://investorshangout.com/post/view?id=4460...z4dI7K5XhI
It is all about funding. Cellceutix should re-apply for grants. I'd love to see NIH come forward and cherry pick but I doubt that's how they work.
Read More: http://investorshangout.com/post/view?id=4460...z4dI7K5XhI
It is all about funding. Cellceutix should re-apply for grants. I'd love to see NIH come forward and cherry pick but I doubt that's how they work.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)